Share Price and Basic Stock Data
Last Updated: February 3, 2026, 3:38 am
| PEG Ratio | 3.71 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cenlub Industries Ltd operates within the engineering sector, focusing on manufacturing lubrication systems. The company reported a market capitalization of ₹85.3 Cr, with a share price of ₹183. Revenue has demonstrated a consistent upward trajectory, with sales increasing from ₹52.42 Cr in FY 2022 to ₹53.93 Cr in FY 2023, and projected at ₹71.52 Cr for FY 2024. The quarterly sales figures also indicate robust growth, peaking at ₹20.14 Cr in December 2023 and ₹19.36 Cr in September 2023, showcasing a significant recovery from the dip to ₹11.13 Cr in March 2023. This growth can be attributed to an increase in demand for lubrication solutions across various industries, indicating a strengthening market position. The company’s ability to maintain positive sales momentum is essential for sustaining its competitive edge in the engineering sector.
Profitability and Efficiency Metrics
Cenlub Industries reported an operating profit margin (OPM) of 12.03%, reflecting effective cost management strategies, despite experiencing fluctuations in quarterly performance. The OPM varied significantly from a low of 0.00% in March 2023 to a high of 29.71% in December 2022. The company’s net profit stood at ₹8.06 Cr, with a return on equity (ROE) of 14.7%, suggesting efficient utilization of shareholders’ equity. The interest coverage ratio (ICR) was reported at 2.97x, indicating that the company comfortably covers its interest obligations, a critical factor for financial stability. However, the cash conversion cycle (CCC) of 105 days reflects room for improvement in operational efficiency, as a lower CCC is generally preferred in the engineering industry. Overall, while profitability metrics are solid, enhancing operational efficiency remains a key area of focus for Cenlub Industries.
Balance Sheet Strength and Financial Ratios
The financial health of Cenlub Industries is underscored by its balance sheet, which reported total assets of ₹90.28 Cr and total liabilities of ₹90.28 Cr as of March 2025. The company maintains a conservative borrowing strategy, with total borrowings recorded at ₹4.27 Cr, which is manageable given its reserves of ₹63.46 Cr. The debt-to-equity ratio stands at 0.09, indicating a low level of financial leverage, which contributes to its strong liquidity position. Furthermore, the price-to-book value (P/BV) ratio is 1.36x, suggesting that the stock is reasonably valued compared to its net asset value. The return on capital employed (ROCE) of 20.5% indicates effective capital utilization, positioning the company favorably against industry benchmarks. Such financial ratios reflect a well-capitalized firm with sound financial practices, although a careful approach to managing its liquidity will be crucial in maintaining its operational stability.
Shareholding Pattern and Investor Confidence
The shareholding structure of Cenlub Industries indicates a stable ownership base, with promoters holding 51.34% of the equity. This significant stake reflects a strong commitment from the founding members, instilling confidence among public investors, who own the remaining 48.66%. The total number of shareholders increased from 4,739 in December 2022 to 8,687 by September 2025, showcasing growing investor interest and confidence in the company’s prospects. Notably, there is no reported foreign institutional investor (FII) or domestic institutional investor (DII) participation, which could point to potential untapped market opportunities. This absence may also suggest a need for the company to enhance its visibility among institutional investors. The consistent promoter holding and growing retail shareholder base are positive indicators for future capital raising initiatives and support for the stock price.
Outlook, Risks, and Final Insight
The outlook for Cenlub Industries appears promising, driven by its strong revenue growth and solid profitability metrics. However, risks include potential fluctuations in raw material prices and supply chain disruptions, which could impact margins. Additionally, the company’s relatively high cash conversion cycle may hinder liquidity in the short term. To leverage growth opportunities, Cenlub should focus on improving operational efficiency and enhancing its product offerings. Furthermore, attracting institutional investors could provide additional capital for expansion and enhance market credibility. The combination of a robust balance sheet, committed management, and increasing shareholder interest positions Cenlub favorably in the engineering sector, though it must remain vigilant against external economic pressures and operational challenges to sustain its growth trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 184 Cr. | 542 | 1,028/511 | 14.7 | 218 | 0.55 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 24.9 Cr. | 83.0 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 5.04 Cr. | 11.6 | 16.4/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 7.33 Cr. | 11.9 | 16.0/10.3 | 4.68 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 40.1 Cr. | 0.43 | 5.03/0.40 | 4.82 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,581.39 Cr | 447.62 | 36.07 | 118.59 | 0.31% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14.35 | 15.62 | 11.13 | 12.21 | 19.36 | 20.14 | 19.81 | 19.09 | 16.88 | 16.71 | 20.68 | 13.98 | 21.12 |
| Expenses | 12.00 | 10.98 | 11.13 | 10.04 | 15.54 | 16.79 | 16.95 | 15.97 | 14.16 | 14.42 | 17.18 | 12.25 | 18.58 |
| Operating Profit | 2.35 | 4.64 | 0.00 | 2.17 | 3.82 | 3.35 | 2.86 | 3.12 | 2.72 | 2.29 | 3.50 | 1.73 | 2.54 |
| OPM % | 16.38% | 29.71% | 0.00% | 17.77% | 19.73% | 16.63% | 14.44% | 16.34% | 16.11% | 13.70% | 16.92% | 12.37% | 12.03% |
| Other Income | 0.13 | 0.29 | 0.50 | 0.12 | 0.27 | 0.36 | 0.50 | 0.38 | 0.55 | 0.65 | 0.96 | 0.60 | 0.50 |
| Interest | 0.09 | 0.03 | 0.03 | 0.11 | 0.13 | 0.07 | 0.10 | 0.05 | 0.09 | 0.16 | 0.11 | 0.10 | 0.16 |
| Depreciation | 0.37 | 0.13 | 0.11 | 0.20 | 0.18 | 0.23 | 0.22 | 0.17 | 0.19 | 0.20 | 0.28 | 0.20 | 0.26 |
| Profit before tax | 2.02 | 4.77 | 0.36 | 1.98 | 3.78 | 3.41 | 3.04 | 3.28 | 2.99 | 2.58 | 4.07 | 2.03 | 2.62 |
| Tax % | 25.25% | 25.58% | 41.67% | 25.25% | 22.22% | 28.45% | 30.26% | 25.30% | 36.12% | 25.19% | 35.38% | 25.12% | 25.19% |
| Net Profit | 1.51 | 3.54 | 0.21 | 1.48 | 2.94 | 2.44 | 2.11 | 2.46 | 1.91 | 1.94 | 2.64 | 1.52 | 1.96 |
| EPS in Rs | 3.24 | 7.59 | 0.45 | 3.17 | 6.31 | 5.23 | 4.53 | 5.28 | 4.10 | 4.16 | 5.66 | 3.26 | 4.20 |
Last Updated: December 27, 2025, 3:03 pm
Below is a detailed analysis of the quarterly data for Cenlub Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 21.12 Cr.. The value appears strong and on an upward trend. It has increased from 13.98 Cr. (Jun 2025) to 21.12 Cr., marking an increase of 7.14 Cr..
- For Expenses, as of Sep 2025, the value is 18.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.25 Cr. (Jun 2025) to 18.58 Cr., marking an increase of 6.33 Cr..
- For Operating Profit, as of Sep 2025, the value is 2.54 Cr.. The value appears strong and on an upward trend. It has increased from 1.73 Cr. (Jun 2025) to 2.54 Cr., marking an increase of 0.81 Cr..
- For OPM %, as of Sep 2025, the value is 12.03%. The value appears to be declining and may need further review. It has decreased from 12.37% (Jun 2025) to 12.03%, marking a decrease of 0.34%.
- For Other Income, as of Sep 2025, the value is 0.50 Cr.. The value appears to be declining and may need further review. It has decreased from 0.60 Cr. (Jun 2025) to 0.50 Cr., marking a decrease of 0.10 Cr..
- For Interest, as of Sep 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.10 Cr. (Jun 2025) to 0.16 Cr., marking an increase of 0.06 Cr..
- For Depreciation, as of Sep 2025, the value is 0.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.20 Cr. (Jun 2025) to 0.26 Cr., marking an increase of 0.06 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.62 Cr.. The value appears strong and on an upward trend. It has increased from 2.03 Cr. (Jun 2025) to 2.62 Cr., marking an increase of 0.59 Cr..
- For Tax %, as of Sep 2025, the value is 25.19%. The value appears to be increasing, which may not be favorable. It has increased from 25.12% (Jun 2025) to 25.19%, marking an increase of 0.07%.
- For Net Profit, as of Sep 2025, the value is 1.96 Cr.. The value appears strong and on an upward trend. It has increased from 1.52 Cr. (Jun 2025) to 1.96 Cr., marking an increase of 0.44 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.20. The value appears strong and on an upward trend. It has increased from 3.26 (Jun 2025) to 4.20, marking an increase of 0.94.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:00 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.48 | 29.82 | 31.34 | 35.67 | 37.11 | 48.10 | 39.04 | 40.96 | 52.42 | 53.93 | 71.52 | 73.37 | 72.49 |
| Expenses | 23.31 | 26.16 | 28.08 | 30.67 | 31.38 | 40.13 | 35.11 | 34.54 | 43.64 | 45.11 | 59.32 | 61.74 | 62.43 |
| Operating Profit | 2.17 | 3.66 | 3.26 | 5.00 | 5.73 | 7.97 | 3.93 | 6.42 | 8.78 | 8.82 | 12.20 | 11.63 | 10.06 |
| OPM % | 8.52% | 12.27% | 10.40% | 14.02% | 15.44% | 16.57% | 10.07% | 15.67% | 16.75% | 16.35% | 17.06% | 15.85% | 13.88% |
| Other Income | 0.57 | 0.52 | 0.72 | 0.93 | 1.01 | 1.45 | 2.20 | 1.37 | 1.40 | 1.27 | 1.25 | 2.54 | 2.71 |
| Interest | 1.98 | 2.01 | 1.90 | 1.81 | 1.21 | 1.22 | 1.10 | 1.07 | 0.59 | 0.26 | 0.41 | 0.40 | 0.53 |
| Depreciation | 0.36 | 0.40 | 0.55 | 0.75 | 0.78 | 1.01 | 0.97 | 0.96 | 0.92 | 0.80 | 0.83 | 0.83 | 0.94 |
| Profit before tax | 0.40 | 1.77 | 1.53 | 3.37 | 4.75 | 7.19 | 4.06 | 5.76 | 8.67 | 9.03 | 12.21 | 12.94 | 11.30 |
| Tax % | 32.50% | 32.20% | 34.64% | 35.01% | 26.95% | 31.29% | 32.27% | 30.38% | 19.26% | 26.14% | 26.45% | 30.91% | |
| Net Profit | 0.28 | 1.19 | 1.00 | 2.19 | 3.48 | 4.94 | 2.76 | 4.01 | 7.00 | 6.67 | 8.97 | 8.94 | 8.06 |
| EPS in Rs | 0.68 | 2.89 | 2.43 | 5.32 | 7.46 | 10.59 | 5.92 | 8.60 | 15.01 | 14.30 | 19.24 | 19.17 | 17.28 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 23.58% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 325.00% | -15.97% | 119.00% | 58.90% | 41.95% | -44.13% | 45.29% | 74.56% | -4.71% | 34.48% | -0.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -340.97% | 134.97% | -60.10% | -16.95% | -86.08% | 89.42% | 29.27% | -79.28% | 39.20% | -34.82% |
Cenlub Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 13% |
| 3 Years: | 12% |
| TTM: | -13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 34% |
| 3 Years: | 8% |
| TTM: | -20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 54% |
| 3 Years: | 30% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: December 10, 2025, 4:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.12 | 4.12 | 4.12 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 | 4.66 |
| Reserves | 9.74 | 10.93 | 11.99 | 15.16 | 18.65 | 23.55 | 24.77 | 28.89 | 35.88 | 42.57 | 51.25 | 59.98 | 63.46 |
| Borrowings | 14.27 | 15.37 | 11.37 | 16.91 | 10.68 | 10.19 | 12.46 | 8.03 | 6.02 | 4.88 | 4.24 | 4.56 | 4.27 |
| Other Liabilities | 7.56 | 7.83 | 9.49 | 9.63 | 11.55 | 13.92 | 12.10 | 14.33 | 12.99 | 10.61 | 17.49 | 21.08 | 19.62 |
| Total Liabilities | 35.69 | 38.25 | 36.97 | 46.36 | 45.54 | 52.32 | 53.99 | 55.91 | 59.55 | 62.72 | 77.64 | 90.28 | 92.01 |
| Fixed Assets | 5.69 | 6.88 | 9.86 | 20.50 | 18.98 | 20.87 | 20.65 | 20.08 | 19.39 | 19.77 | 17.43 | 23.46 | 25.53 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.27 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Investments | 1.04 | 4.56 | 1.60 | 0.07 | 0.06 | 0.05 | 0.02 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 28.96 | 26.81 | 25.51 | 25.52 | 26.18 | 31.40 | 33.32 | 35.77 | 40.16 | 42.95 | 60.21 | 66.80 | 66.48 |
| Total Assets | 35.69 | 38.25 | 36.97 | 46.36 | 45.54 | 52.32 | 53.99 | 55.91 | 59.55 | 62.72 | 77.64 | 90.28 | 92.01 |
Below is a detailed analysis of the balance sheet data for Cenlub Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.66 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.66 Cr..
- For Reserves, as of Sep 2025, the value is 63.46 Cr.. The value appears strong and on an upward trend. It has increased from 59.98 Cr. (Mar 2025) to 63.46 Cr., marking an increase of 3.48 Cr..
- For Borrowings, as of Sep 2025, the value is 4.27 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 4.56 Cr. (Mar 2025) to 4.27 Cr., marking a decrease of 0.29 Cr..
- For Other Liabilities, as of Sep 2025, the value is 19.62 Cr.. The value appears to be improving (decreasing). It has decreased from 21.08 Cr. (Mar 2025) to 19.62 Cr., marking a decrease of 1.46 Cr..
- For Total Liabilities, as of Sep 2025, the value is 92.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.28 Cr. (Mar 2025) to 92.01 Cr., marking an increase of 1.73 Cr..
- For Fixed Assets, as of Sep 2025, the value is 25.53 Cr.. The value appears strong and on an upward trend. It has increased from 23.46 Cr. (Mar 2025) to 25.53 Cr., marking an increase of 2.07 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 66.48 Cr.. The value appears to be declining and may need further review. It has decreased from 66.80 Cr. (Mar 2025) to 66.48 Cr., marking a decrease of 0.32 Cr..
- For Total Assets, as of Sep 2025, the value is 92.01 Cr.. The value appears strong and on an upward trend. It has increased from 90.28 Cr. (Mar 2025) to 92.01 Cr., marking an increase of 1.73 Cr..
Notably, the Reserves (63.46 Cr.) exceed the Borrowings (4.27 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -12.10 | -11.71 | -8.11 | -11.91 | -4.95 | -2.22 | -8.53 | -1.61 | 2.76 | 3.94 | 7.96 | 7.07 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 104.86 | 81.89 | 95.85 | 107.85 | 104.75 | 97.97 | 117.15 | 152.74 | 118.16 | 84.26 | 48.69 | 81.29 |
| Inventory Days | 122.33 | 122.96 | 125.55 | 97.65 | 94.25 | 48.38 | 86.94 | 26.46 | 44.52 | 73.29 | 85.42 | 83.60 |
| Days Payable | 116.39 | 103.11 | 133.73 | 112.70 | 125.12 | 100.77 | 129.33 | 116.19 | 107.32 | 91.02 | 70.78 | 59.89 |
| Cash Conversion Cycle | 110.79 | 101.73 | 87.67 | 92.80 | 73.88 | 45.57 | 74.76 | 63.01 | 55.36 | 66.53 | 63.33 | 105.00 |
| Working Capital Days | -51.28 | -58.39 | -26.90 | -19.34 | -1.67 | -14.04 | -21.04 | 15.51 | 31.40 | 34.31 | -2.76 | 11.49 |
| ROCE % | 9.41% | 12.54% | 11.88% | 14.95% | 15.55% | 21.49% | 10.26% | 16.34% | 20.97% | 18.81% | 22.47% | 20.47% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.24 | 2.44 | 2.88 | 0.69 | 5.39 |
| Diluted EPS (Rs.) | 4.24 | 2.44 | 2.88 | 0.69 | 5.39 |
| Cash EPS (Rs.) | 5.99 | 3.77 | 3.86 | 1.67 | 6.26 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 43.29 | 39.05 | 36.45 | 33.58 | 32.89 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 43.29 | 39.05 | 36.45 | 33.58 | 32.89 |
| Revenue From Operations / Share (Rs.) | 86.25 | 76.07 | 72.37 | 61.86 | 80.68 |
| PBDIT / Share (Rs.) | 13.05 | 10.30 | 10.14 | 6.78 | 12.12 |
| PBIT / Share (Rs.) | 11.30 | 8.97 | 9.16 | 5.80 | 11.24 |
| PBT / Share (Rs.) | 6.90 | 3.73 | 4.27 | 0.99 | 7.83 |
| Net Profit / Share (Rs.) | 4.24 | 2.44 | 2.88 | 0.68 | 5.38 |
| NP After MI And SOA / Share (Rs.) | 4.24 | 2.44 | 2.88 | 0.68 | 5.38 |
| PBDIT Margin (%) | 15.13 | 13.54 | 14.01 | 10.96 | 15.01 |
| PBIT Margin (%) | 13.10 | 11.79 | 12.65 | 9.37 | 13.93 |
| PBT Margin (%) | 7.99 | 4.90 | 5.90 | 1.61 | 9.70 |
| Net Profit Margin (%) | 4.92 | 3.20 | 3.97 | 1.11 | 6.67 |
| NP After MI And SOA Margin (%) | 4.92 | 3.20 | 3.97 | 1.11 | 6.67 |
| Return on Networth / Equity (%) | 9.80 | 6.24 | 7.89 | 2.04 | 16.37 |
| Return on Capital Employeed (%) | 18.04 | 14.61 | 18.75 | 12.66 | 25.77 |
| Return On Assets (%) | 3.94 | 2.34 | 3.09 | 0.79 | 6.93 |
| Long Term Debt / Equity (X) | 0.38 | 0.49 | 0.26 | 0.29 | 0.26 |
| Total Debt / Equity (X) | 0.90 | 1.07 | 0.93 | 0.96 | 0.86 |
| Asset Turnover Ratio (%) | 0.79 | 0.83 | 0.80 | 0.75 | 1.13 |
| Current Ratio (X) | 1.32 | 1.29 | 1.00 | 1.22 | 1.26 |
| Quick Ratio (X) | 1.05 | 0.94 | 0.68 | 0.92 | 1.05 |
| Inventory Turnover Ratio (X) | 3.14 | 3.16 | 3.21 | 3.89 | 5.21 |
| Interest Coverage Ratio (X) | 2.97 | 1.97 | 2.07 | 1.41 | 3.55 |
| Interest Coverage Ratio (Post Tax) (X) | 1.96 | 1.47 | 1.59 | 1.14 | 2.58 |
| Enterprise Value (Cr.) | 32.07 | 17.74 | 19.77 | 13.95 | 17.73 |
| EV / Net Operating Revenue (X) | 0.90 | 0.56 | 0.66 | 0.54 | 0.53 |
| EV / EBITDA (X) | 5.96 | 4.18 | 4.73 | 4.99 | 3.55 |
| MarketCap / Net Operating Revenue (X) | 0.68 | 0.24 | 0.35 | 0.30 | 0.35 |
| Price / BV (X) | 1.36 | 0.48 | 0.70 | 0.56 | 0.86 |
| Price / Net Operating Revenue (X) | 0.68 | 0.24 | 0.35 | 0.30 | 0.35 |
| EarningsYield | 0.07 | 0.12 | 0.11 | 0.03 | 0.18 |
After reviewing the key financial ratios for Cenlub Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 17, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For Diluted EPS (Rs.), as of Mar 17, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For Cash EPS (Rs.), as of Mar 17, the value is 5.99. This value is within the healthy range. It has increased from 3.77 (Mar 16) to 5.99, marking an increase of 2.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 43.29. It has increased from 39.05 (Mar 16) to 43.29, marking an increase of 4.24.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 43.29. It has increased from 39.05 (Mar 16) to 43.29, marking an increase of 4.24.
- For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 86.25. It has increased from 76.07 (Mar 16) to 86.25, marking an increase of 10.18.
- For PBDIT / Share (Rs.), as of Mar 17, the value is 13.05. This value is within the healthy range. It has increased from 10.30 (Mar 16) to 13.05, marking an increase of 2.75.
- For PBIT / Share (Rs.), as of Mar 17, the value is 11.30. This value is within the healthy range. It has increased from 8.97 (Mar 16) to 11.30, marking an increase of 2.33.
- For PBT / Share (Rs.), as of Mar 17, the value is 6.90. This value is within the healthy range. It has increased from 3.73 (Mar 16) to 6.90, marking an increase of 3.17.
- For Net Profit / Share (Rs.), as of Mar 17, the value is 4.24. This value is within the healthy range. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 4.24. This value is within the healthy range. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
- For PBDIT Margin (%), as of Mar 17, the value is 15.13. This value is within the healthy range. It has increased from 13.54 (Mar 16) to 15.13, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 17, the value is 13.10. This value is within the healthy range. It has increased from 11.79 (Mar 16) to 13.10, marking an increase of 1.31.
- For PBT Margin (%), as of Mar 17, the value is 7.99. This value is below the healthy minimum of 10. It has increased from 4.90 (Mar 16) to 7.99, marking an increase of 3.09.
- For Net Profit Margin (%), as of Mar 17, the value is 4.92. This value is below the healthy minimum of 5. It has increased from 3.20 (Mar 16) to 4.92, marking an increase of 1.72.
- For NP After MI And SOA Margin (%), as of Mar 17, the value is 4.92. This value is below the healthy minimum of 8. It has increased from 3.20 (Mar 16) to 4.92, marking an increase of 1.72.
- For Return on Networth / Equity (%), as of Mar 17, the value is 9.80. This value is below the healthy minimum of 15. It has increased from 6.24 (Mar 16) to 9.80, marking an increase of 3.56.
- For Return on Capital Employeed (%), as of Mar 17, the value is 18.04. This value is within the healthy range. It has increased from 14.61 (Mar 16) to 18.04, marking an increase of 3.43.
- For Return On Assets (%), as of Mar 17, the value is 3.94. This value is below the healthy minimum of 5. It has increased from 2.34 (Mar 16) to 3.94, marking an increase of 1.60.
- For Long Term Debt / Equity (X), as of Mar 17, the value is 0.38. This value is within the healthy range. It has decreased from 0.49 (Mar 16) to 0.38, marking a decrease of 0.11.
- For Total Debt / Equity (X), as of Mar 17, the value is 0.90. This value is within the healthy range. It has decreased from 1.07 (Mar 16) to 0.90, marking a decrease of 0.17.
- For Asset Turnover Ratio (%), as of Mar 17, the value is 0.79. It has decreased from 0.83 (Mar 16) to 0.79, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 17, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.29 (Mar 16) to 1.32, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 17, the value is 1.05. This value is within the healthy range. It has increased from 0.94 (Mar 16) to 1.05, marking an increase of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 17, the value is 3.14. This value is below the healthy minimum of 4. It has decreased from 3.16 (Mar 16) to 3.14, marking a decrease of 0.02.
- For Interest Coverage Ratio (X), as of Mar 17, the value is 2.97. This value is below the healthy minimum of 3. It has increased from 1.97 (Mar 16) to 2.97, marking an increase of 1.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 1.96. This value is below the healthy minimum of 3. It has increased from 1.47 (Mar 16) to 1.96, marking an increase of 0.49.
- For Enterprise Value (Cr.), as of Mar 17, the value is 32.07. It has increased from 17.74 (Mar 16) to 32.07, marking an increase of 14.33.
- For EV / Net Operating Revenue (X), as of Mar 17, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 16) to 0.90, marking an increase of 0.34.
- For EV / EBITDA (X), as of Mar 17, the value is 5.96. This value is within the healthy range. It has increased from 4.18 (Mar 16) to 5.96, marking an increase of 1.78.
- For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 16) to 0.68, marking an increase of 0.44.
- For Price / BV (X), as of Mar 17, the value is 1.36. This value is within the healthy range. It has increased from 0.48 (Mar 16) to 1.36, marking an increase of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 17, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 16) to 0.68, marking an increase of 0.44.
- For EarningsYield, as of Mar 17, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 16) to 0.07, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cenlub Industries Ltd:
- Net Profit Margin: 4.92%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.04% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.8% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.96
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.6 (Industry average Stock P/E: 36.07)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.9
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.92%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | Plot No. 233 & 234, Sector-58, Faridabad Haryana 121004 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Madhu Mittal | Chairman & Managing Director |
| Mr. Aman Mittal | Whole Time Director |
| Mr. Ansh Mittal | Whole Time Director |
| Mr. Dinesh Kaushal | Independent Director |
| Mr. Kamlesh Kumar Johari | Independent Director |
| Mr. Tarun Kumar Gupta | Independent Director |
FAQ
What is the intrinsic value of Cenlub Industries Ltd?
Cenlub Industries Ltd's intrinsic value (as of 05 February 2026) is ₹190.94 which is 4.34% higher the current market price of ₹183.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹85.3 Cr. market cap, FY2025-2026 high/low of ₹490/176, reserves of ₹63.46 Cr, and liabilities of ₹92.01 Cr.
What is the Market Cap of Cenlub Industries Ltd?
The Market Cap of Cenlub Industries Ltd is 85.3 Cr..
What is the current Stock Price of Cenlub Industries Ltd as on 05 February 2026?
The current stock price of Cenlub Industries Ltd as on 05 February 2026 is ₹183.
What is the High / Low of Cenlub Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cenlub Industries Ltd stocks is ₹490/176.
What is the Stock P/E of Cenlub Industries Ltd?
The Stock P/E of Cenlub Industries Ltd is 10.6.
What is the Book Value of Cenlub Industries Ltd?
The Book Value of Cenlub Industries Ltd is 146.
What is the Dividend Yield of Cenlub Industries Ltd?
The Dividend Yield of Cenlub Industries Ltd is 0.00 %.
What is the ROCE of Cenlub Industries Ltd?
The ROCE of Cenlub Industries Ltd is 20.5 %.
What is the ROE of Cenlub Industries Ltd?
The ROE of Cenlub Industries Ltd is 14.7 %.
What is the Face Value of Cenlub Industries Ltd?
The Face Value of Cenlub Industries Ltd is 10.0.